Araştırma Makalesi
BibTex RIS Kaynak Göster

Yıl 2024, Cilt: 37 Sayı: 1, 53 - 58, 28.01.2024

Merve Başalan Mümtaz Takır Cündullah Torun Medeni Sermet

https://doi.org/10.5472/marumj.1381218

Öz

Kaynakça

  • Powell-Wiley TM, Poirier P, Burke LE, et al. Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 2021; 143:e984-e1010. doi: 10.1161/CIR.000.000.0000000973.
  • Leitner DR, Frühbeck G, Yumuk V, et al. Obesity and type 2 diabetes: two diseases with a need for combined treatment strategies – EASO can lead the way. Obes Facts 2017; 10:483- 92. doi: 10.1159/000480525.
  • Kopp W. How Western diet and lifestyle drive the pandemic of obesity and civilization diseases. Diabetes Metab Syndr Obes 2019; 12:2221-36. doi: 10.2147/DMSO.S216791.
  • Hruby A, Hu FB. The epidemiology of obesity: a big picture. Pharmacoeconomics 2015; 33:673-89. doi: 10.1007/ s40273.014.0243-x.
  • Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome. A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society and International Association for the Study of Obesity. Circulation 2009; 120:1640-5. doi: 10.1161/CIRCULATIONAHA.
  • O’Neill S, O’Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev 2015; 16:1-12. doi: 10.1111/obr.12229.
  • Abacı A, Kılıçkap M, Göksülük H, et al. Türkiye’de metabolik sendrom sıklığı verileri: Kardiyovasküler risk faktörlerine yönelik epidemiyolojik çalışmaların sistematik derleme, metaanaliz ve meta-regresyonu [Data on prevalence of metabolic syndrome in Turkey: Systematic review, meta-analysis and meta-regression of epidemiological studies on cardiovascular risk factors]. Turk Kardiyol Dern Ars 2018; 46:591-601. Turkish. doi: 10.5543/tkda.2018.00878.
  • Shi X, Karmali S, Sharma AM, Birch DW. A review of laparoscopic sleeve gastrectomy for morbid obesity. Obes Surg 2010; 20:1171-7. doi: 10.1007/s11695.010.0145-8.
  • Garvey WT, Mechanick JI, Brett EM, et al. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical Practice Guidelines for medical care of patients with obesity. Endocr Pract 2016;22 Suppl3:1-203. doi: 10.4158/EP161365.GL
  • Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112:2735-52. doi: 10.1161/CIRCULATIONAHA.105.169404.
  • Sowemimo OA, Yood SM, Courtney J, et al. Natural history of morbid obesity without surgical intervention. Surg Obes Relat Dis 2007 ;3:73-7. doi: 10.1016/j.soard.2006.10.017.
  • Ruban A, Stoenchev K, Ashrafian H, Teare J. Current treatments for obesity. Clin Med (Lond) 2019; 19:205-12. doi: 10.7861/clinmedicine.19-3-205.
  • Anderson JW, Konz EC, Frederich RC, Wood CL. Long-term weight-loss maintenance: a metaanalysis of US studies. Am J Clin Nutr 2001; 74:579-84. doi: 10.1093/ajcn/74.5.579.
  • Palermo M, Gagner M. Why we think laparoscopic sleeve gastrectomy ıs a good operation: step-by-step technique. J Laparoendosc Adv Surg Tech A 2020; 30:615-18. doi: 10.1089/ lap.2020.0154.
  • Péquignot A, Dhahri A, Verhaeghe P, Desailloud R, Lalau J-D, Regimbeau J-M. Efficiency of laparoscopic sleeve gastrectomy on metabolic syndrome disorders: two years results. J Visc Surg 2012; 149:e350-e5. doi: 10.1016/j. jviscsurg.2012.06.005.
  • Elhag W, El Ansari W, Abdulrazzaq S, Abdullah A, Elsherif M, Elgenaied I. Evolution of 29 anthropometric, nutritional, and cardiometabolic parameters among morbidly obese adolescents 2 years post sleeve gastrectomy. Obes Surg 2018;28:474-82. doi: 10.1007/s11695.017.2868-2.
  • Wojciak PA, Pawłuszewicz P, Diemieszczyk I, et al. Laparoscopic sleeve gastrectomy: a study of efficiency in treatment of metabolic syndrome components, comorbidities and influence on certain biochemical markers. Videosurgery Miniinv 2020; 15:136-47. doi: 10.5114/wiitm.2019.84718.
  • Smeu B, Balescu I, Sarbu A, Fica S, Copaescu C. Early improvement in glycemic metabolism after laparoscopic sleeve gastrectomy in obese patients–a prospective study. Chirurgia (Bucur) 2015; 110:430-9.
  • Graham C, Switzer N, Reso A, et al. Sleeve gastrectomy and hypertension: a systematic review of long-term outcomes. Surg Endosc 2019; 33:3001-7. doi: 10.1007/s00464.018.6566-5.
  • Samson R, Milligan G, Lewine E, et al. Effect of sleeve gastrectomy on hypertension. J Am Soc Hyperten 2018; 12:e19-e25. doi: 10.1016/j.jash.2018.09.007.
  • Sharma C, Platat C, Gariballa S, et al. Metabolomic profiling of lipids and fatty acids: 3 years postoperative laparoscopic sleeve gastrectomy. Biology 2021; 10:298. doi:10.3390/ biology10040298
  • Shabbir A, Dargan D. The success of sleeve gastrectomy in the management of metabolic syndrome and obesity. J Biomed Res 2015; 29:93. doi:10.7555/JBR.28.20140107
  • Salman MA, Salman AA, Omar HS, et al. Long-term effects of one-anastomosis gastric bypass on liver histopathology in NAFLD cases: A prospective study. Surg Endosc 2021; 35:1889-94. doi:10.1007/s00464.020.07725-y.
  • Elyasinia F, Jalali SM, Zarini S, Sadeghian E, Sorush A, Pirouz A. The effect of laparoscopic sleeve gastrectomy and gastric bypass surgery on non-alcoholic steatohepatitis in Iranian patients with obesity. Middle East J Dig Dis 2021; 13:200-207. doi:10.34172/mejdd.2021.226
  • Gagner M, Deitel M, Erickson AL, Crosby RD. Survey on laparoscopic sleeve gastrectomy (LSG) at the Fourth International Consensus Summit on Sleeve Gastrectomy. Obes Surg 2013; 23:2013-7. doi: 10.1007/s11695.013.1040-x.

The effect of laparoscopic sleeve gastrectomy on metabolic syndrome parameters during one year of follow-up

Yıl 2024, Cilt: 37 Sayı: 1, 53 - 58, 28.01.2024

Merve Başalan Mümtaz Takır Cündullah Torun Medeni Sermet

https://doi.org/10.5472/marumj.1381218

Öz

Objective: We aimed to evaluate the effectiveness of laparoscopic sleeve gastrectomy (LSG) as a treatment method for morbid obesity
and its impact on reducing the incidence of metabolic syndrome and its components.
Patients and Methods: This retrospective and a single-center study included patients with obesity who underwent LSG and were
followed up at an endocrinology and metabolism outpatient clinic for at least one year. Anthropometric measurements, blood pressure,
and blood examinations including fasting plasma glucose and lipid profile were assessed before the surgery and one year after the
surgery. The presence of metabolic syndrome and related comorbidities was documented.
Results: The study included 62 patients, with a mean age of 38.2 ± 8 years and a female predominance (88.7%). At one year post-surgery,
significant improvements were observed in body weight, waist circumference, blood pressure, and metabolic parameters (P<0.001 for
all). The prevalence of metabolic syndrome decreased from 66.1% to 6.5% (P<0.001). The prevalence of diabetes, hypertension, and
hepatosteatosis also decreased significantly (P<0.05).
Conclusion: Laparoscopic sleeve gastrectomy demonstrates substantial weight loss and positive effects on metabolic syndrome
components. The procedure appears to be an effective intervention for obese patients with obesity-related comorbidities. Longer-term
prospective studies are needed to further validate these promising results.

Anahtar Kelimeler

Obesity Bariatric surgery Metabolic syndrome

Kaynakça

  • Powell-Wiley TM, Poirier P, Burke LE, et al. Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 2021; 143:e984-e1010. doi: 10.1161/CIR.000.000.0000000973.
  • Leitner DR, Frühbeck G, Yumuk V, et al. Obesity and type 2 diabetes: two diseases with a need for combined treatment strategies – EASO can lead the way. Obes Facts 2017; 10:483- 92. doi: 10.1159/000480525.
  • Kopp W. How Western diet and lifestyle drive the pandemic of obesity and civilization diseases. Diabetes Metab Syndr Obes 2019; 12:2221-36. doi: 10.2147/DMSO.S216791.
  • Hruby A, Hu FB. The epidemiology of obesity: a big picture. Pharmacoeconomics 2015; 33:673-89. doi: 10.1007/ s40273.014.0243-x.
  • Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome. A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society and International Association for the Study of Obesity. Circulation 2009; 120:1640-5. doi: 10.1161/CIRCULATIONAHA.
  • O’Neill S, O’Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev 2015; 16:1-12. doi: 10.1111/obr.12229.
  • Abacı A, Kılıçkap M, Göksülük H, et al. Türkiye’de metabolik sendrom sıklığı verileri: Kardiyovasküler risk faktörlerine yönelik epidemiyolojik çalışmaların sistematik derleme, metaanaliz ve meta-regresyonu [Data on prevalence of metabolic syndrome in Turkey: Systematic review, meta-analysis and meta-regression of epidemiological studies on cardiovascular risk factors]. Turk Kardiyol Dern Ars 2018; 46:591-601. Turkish. doi: 10.5543/tkda.2018.00878.
  • Shi X, Karmali S, Sharma AM, Birch DW. A review of laparoscopic sleeve gastrectomy for morbid obesity. Obes Surg 2010; 20:1171-7. doi: 10.1007/s11695.010.0145-8.
  • Garvey WT, Mechanick JI, Brett EM, et al. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical Practice Guidelines for medical care of patients with obesity. Endocr Pract 2016;22 Suppl3:1-203. doi: 10.4158/EP161365.GL
  • Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112:2735-52. doi: 10.1161/CIRCULATIONAHA.105.169404.
  • Sowemimo OA, Yood SM, Courtney J, et al. Natural history of morbid obesity without surgical intervention. Surg Obes Relat Dis 2007 ;3:73-7. doi: 10.1016/j.soard.2006.10.017.
  • Ruban A, Stoenchev K, Ashrafian H, Teare J. Current treatments for obesity. Clin Med (Lond) 2019; 19:205-12. doi: 10.7861/clinmedicine.19-3-205.
  • Anderson JW, Konz EC, Frederich RC, Wood CL. Long-term weight-loss maintenance: a metaanalysis of US studies. Am J Clin Nutr 2001; 74:579-84. doi: 10.1093/ajcn/74.5.579.
  • Palermo M, Gagner M. Why we think laparoscopic sleeve gastrectomy ıs a good operation: step-by-step technique. J Laparoendosc Adv Surg Tech A 2020; 30:615-18. doi: 10.1089/ lap.2020.0154.
  • Péquignot A, Dhahri A, Verhaeghe P, Desailloud R, Lalau J-D, Regimbeau J-M. Efficiency of laparoscopic sleeve gastrectomy on metabolic syndrome disorders: two years results. J Visc Surg 2012; 149:e350-e5. doi: 10.1016/j. jviscsurg.2012.06.005.
  • Elhag W, El Ansari W, Abdulrazzaq S, Abdullah A, Elsherif M, Elgenaied I. Evolution of 29 anthropometric, nutritional, and cardiometabolic parameters among morbidly obese adolescents 2 years post sleeve gastrectomy. Obes Surg 2018;28:474-82. doi: 10.1007/s11695.017.2868-2.
  • Wojciak PA, Pawłuszewicz P, Diemieszczyk I, et al. Laparoscopic sleeve gastrectomy: a study of efficiency in treatment of metabolic syndrome components, comorbidities and influence on certain biochemical markers. Videosurgery Miniinv 2020; 15:136-47. doi: 10.5114/wiitm.2019.84718.
  • Smeu B, Balescu I, Sarbu A, Fica S, Copaescu C. Early improvement in glycemic metabolism after laparoscopic sleeve gastrectomy in obese patients–a prospective study. Chirurgia (Bucur) 2015; 110:430-9.
  • Graham C, Switzer N, Reso A, et al. Sleeve gastrectomy and hypertension: a systematic review of long-term outcomes. Surg Endosc 2019; 33:3001-7. doi: 10.1007/s00464.018.6566-5.
  • Samson R, Milligan G, Lewine E, et al. Effect of sleeve gastrectomy on hypertension. J Am Soc Hyperten 2018; 12:e19-e25. doi: 10.1016/j.jash.2018.09.007.
  • Sharma C, Platat C, Gariballa S, et al. Metabolomic profiling of lipids and fatty acids: 3 years postoperative laparoscopic sleeve gastrectomy. Biology 2021; 10:298. doi:10.3390/ biology10040298
  • Shabbir A, Dargan D. The success of sleeve gastrectomy in the management of metabolic syndrome and obesity. J Biomed Res 2015; 29:93. doi:10.7555/JBR.28.20140107
  • Salman MA, Salman AA, Omar HS, et al. Long-term effects of one-anastomosis gastric bypass on liver histopathology in NAFLD cases: A prospective study. Surg Endosc 2021; 35:1889-94. doi:10.1007/s00464.020.07725-y.
  • Elyasinia F, Jalali SM, Zarini S, Sadeghian E, Sorush A, Pirouz A. The effect of laparoscopic sleeve gastrectomy and gastric bypass surgery on non-alcoholic steatohepatitis in Iranian patients with obesity. Middle East J Dig Dis 2021; 13:200-207. doi:10.34172/mejdd.2021.226
  • Gagner M, Deitel M, Erickson AL, Crosby RD. Survey on laparoscopic sleeve gastrectomy (LSG) at the Fourth International Consensus Summit on Sleeve Gastrectomy. Obes Surg 2013; 23:2013-7. doi: 10.1007/s11695.013.1040-x.
Toplam 25 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Cerrahi (Diğer)
Bölüm Original Research
Yazarlar

Merve Başalan Bu kişi benim

Mümtaz Takır

Cündullah Torun

Medeni Sermet

Yayımlanma Tarihi 28 Ocak 2024
Yayımlandığı Sayı Yıl 2024 Cilt: 37 Sayı: 1

Kaynak Göster

APA Başalan, M., Takır, M., Torun, C., Sermet, M. (2024). The effect of laparoscopic sleeve gastrectomy on metabolic syndrome parameters during one year of follow-up. Marmara Medical Journal, 37(1), 53-58. https://doi.org/10.5472/marumj.1381218
AMA Başalan M, Takır M, Torun C, Sermet M. The effect of laparoscopic sleeve gastrectomy on metabolic syndrome parameters during one year of follow-up. Marmara Med J. Ocak 2024;37(1):53-58. doi:10.5472/marumj.1381218
Chicago Başalan, Merve, Mümtaz Takır, Cündullah Torun, ve Medeni Sermet. “The Effect of Laparoscopic Sleeve Gastrectomy on Metabolic Syndrome Parameters During One Year of Follow-up”. Marmara Medical Journal 37, sy. 1 (Ocak 2024): 53-58. https://doi.org/10.5472/marumj.1381218.
EndNote Başalan M, Takır M, Torun C, Sermet M (01 Ocak 2024) The effect of laparoscopic sleeve gastrectomy on metabolic syndrome parameters during one year of follow-up. Marmara Medical Journal 37 1 53–58.
IEEE M. Başalan, M. Takır, C. Torun, ve M. Sermet, “The effect of laparoscopic sleeve gastrectomy on metabolic syndrome parameters during one year of follow-up”, Marmara Med J, c. 37, sy. 1, ss. 53–58, 2024, doi: 10.5472/marumj.1381218.
ISNAD Başalan, Merve vd. “The Effect of Laparoscopic Sleeve Gastrectomy on Metabolic Syndrome Parameters During One Year of Follow-up”. Marmara Medical Journal 37/1 (Ocak 2024), 53-58. https://doi.org/10.5472/marumj.1381218.
JAMA Başalan M, Takır M, Torun C, Sermet M. The effect of laparoscopic sleeve gastrectomy on metabolic syndrome parameters during one year of follow-up. Marmara Med J. 2024;37:53–58.
MLA Başalan, Merve vd. “The Effect of Laparoscopic Sleeve Gastrectomy on Metabolic Syndrome Parameters During One Year of Follow-up”. Marmara Medical Journal, c. 37, sy. 1, 2024, ss. 53-58, doi:10.5472/marumj.1381218.
Vancouver Başalan M, Takır M, Torun C, Sermet M. The effect of laparoscopic sleeve gastrectomy on metabolic syndrome parameters during one year of follow-up. Marmara Med J. 2024;37(1):53-8.
 Kapak Resmi İndir